The University of Zimbabwe (UZ)-UCSF Program is a GloCal site for Zimbabwean and UC trainees in clinical and implementation research focused on HIV, other infectious diseases and their sequelae. UZ-UCSF was established in 1994 to lead HIV prevention and treatment studies in Zimbabwe. UZ-UCSF is led by Drs. Z. Chirenje (UCSF and UZ), J. Hakim (UZ), and T. Chipato (UZ).
UZ-UCSF has 14 ongoing clinical trials, with 15 in development, and employs over 300 expert research staff at seven research sites. UZ-UCSF has a National Institutes of Health (NIH)-approved Central Laboratory and Pharmacy, provides central fiscal and administrative research support, and collaborates with five NIH-sponsored HIV research networks.
The UZ-UCSF investigators collaborate with UCSF faculty on clinical and implementation research, including:
- Antiretroviral Therapy (ART) for prevention
- Prevention and treatment of tuberculosis and HIV-associated cancers
- Pediatric ART
- Prevention of mother-to-child transmission
- Safer conception
- Sexual and reproductive health integration with HIV care and treatment
- Community HIV testing
- HPV and associated cervical and anal cancers
- HIV testing in adolescents
UZ-UCSF leadership is participating in several NIH-sponsored training programs in Zimbabwe, including the Promoting Excellence in Research and Faculty Enhanced Career Training, Makerere University Medical Educational Partnership Initiative, and the HIV Implementation Science Research Training Program.
Site contact: Dr. Tsungai Chipato